AI Engines For more Details: Perplexity Kagi Labs You
Analgesic Effect: Clonixin lysinate is primarily used to relieve pain of mild to moderate intensity. It exerts its analgesic effects by inhibiting the synthesis of prostaglandins, which are substances involved in the mediation of pain and inflammation. By reducing prostaglandin levels, clonixin lysinate helps alleviate pain associated with conditions such as headache, dental pain, menstrual cramps, musculoskeletal injuries, and postoperative pain.
Anti-inflammatory Effect: Clonixin lysinate possesses anti-inflammatory properties, making it useful in the management of inflammatory conditions such as arthritis, bursitis, tendonitis, and other musculoskeletal disorders. By inhibiting the production of prostaglandins and other inflammatory mediators, clonixin lysinate helps reduce swelling, redness, and stiffness associated with inflammation, thereby improving symptoms and functional mobility.
Antipyretic Effect: In addition to its analgesic and anti-inflammatory effects, clonixin lysinate has antipyretic properties, meaning it can help reduce fever. By inhibiting the synthesis of prostaglandins in the brain's hypothalamus, clonixin lysinate helps lower body temperature and alleviate fever associated with infectious diseases, inflammatory conditions, or other causes.
Rheumatic Conditions: Clonixin lysinate may be prescribed for the management of rheumatic conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. It can help reduce pain, inflammation, and stiffness associated with these conditions, thereby improving joint function and quality of life for affected individuals.
Dosage and Administration: Clonixin lysinate is typically administered orally in the form of tablets or capsules, although intravenous formulations may also be available for certain medical settings. The dosage and frequency of clonixin lysinate therapy depend on factors such as the severity of pain or inflammation, the individual patient's response to treatment, and the specific formulation used. Patients should follow the instructions provided by their healthcare provider or medication label for proper dosing and administration.
Side Effects: Like other NSAIDs, clonixin lysinate may be associated with certain side effects, particularly when used at high doses or for prolonged periods. Common side effects may include gastrointestinal disturbances such as dyspepsia, nausea, vomiting, abdominal pain, and diarrhea. Less common but more serious side effects may include gastrointestinal ulcers or bleeding, cardiovascular events such as heart attack or stroke, renal impairment, allergic reactions, and liver toxicity. Patients should be monitored regularly for signs of adverse effects, especially if they have preexisting medical conditions or risk factors.
Contraindications and Precautions: Clonixin lysinate is contraindicated in individuals with hypersensitivity to NSAIDs or any of their components, as well as in patients with a history of aspirin-induced asthma, peptic ulcer disease, gastrointestinal bleeding, severe renal impairment, or hepatic dysfunction. It should be used with caution in elderly patients, individuals with cardiovascular risk factors, and those taking other medications that may interact with clonixin lysinate.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia hansenii | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Streptococcus thermophilus | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Coprobacter | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 2 | Phocaeicola | genus | Increases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
0 | 1 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Bacteroides sp. HF-162 | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Streptococcus oralis | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Streptococcus sp. Marseille-Q6470 | species | Decreases |
0 | 1 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 431 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Enterocloster bolteae | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Paraprevotella clara | species | Decreases |
0 | 1 | Prevotella bivia | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Parabacteroides johnsonii | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Streptococcus ilei | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Prevotella dentalis | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
2 | 0 | Phocaeicola vulgatus | species | Increases |
0 | 1 | Phocaeicola vulgatus 274-1D4 | strain | Increases |
0 | 1 | Phocaeicola vulgatus ATCC 8482 | strain | Increases |
0 | 1 | Phocaeicola vulgatus CL09T03C04 | strain | Increases |
0 | 1 | Phocaeicola vulgatus dnLKV7 | strain | Increases |
0 | 1 | Phocaeicola vulgatus PC510 | strain | Increases |
0 | 1 | Phocaeicola vulgatus RJ2L3 | strain | Increases |
0 | 1 | Phocaeicola vulgatus str. 3775 SL(B) 10 (iv) | strain | Increases |
0 | 1 | Phocaeicola vulgatus str. 3775 SR(B) 19 | strain | Increases |
0 | 1 | Phocaeicola vulgatus str. 3975 RP4 | strain | Increases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.7 | 0.7 | |
Acne | 0.1 | -0.1 | |
ADHD | 2.7 | 0.2 | 12.5 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.3 | 0.67 |
Allergic Rhinitis (Hay Fever) | 2.5 | 1.7 | 0.47 |
Allergies | 3.9 | 2.2 | 0.77 |
Allergy to milk products | 1.4 | 1.2 | 0.17 |
Alopecia (Hair Loss) | 0.8 | 0.8 | |
Alzheimer's disease | 4.6 | 3.5 | 0.31 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2 | 1 | 1 |
Ankylosing spondylitis | 3.4 | 1.4 | 1.43 |
Anorexia Nervosa | 1.1 | 1.9 | -0.73 |
Antiphospholipid syndrome (APS) | 1.7 | 0.1 | 16 |
Asthma | 3.9 | 0.9 | 3.33 |
Atherosclerosis | 2.4 | 0.7 | 2.43 |
Atrial fibrillation | 2.3 | 1.9 | 0.21 |
Autism | 5.4 | 5.7 | -0.06 |
Autoimmune Disease | 1.1 | 0.1 | 10 |
Barrett esophagus cancer | 0.2 | 0.4 | -1 |
benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
Biofilm | 2.5 | 2.5 | |
Bipolar Disorder | 1.5 | 0.4 | 2.75 |
Brain Trauma | 0.5 | 0.7 | -0.4 |
Breast Cancer | 1.2 | 1.2 | |
Cancer (General) | 0.6 | 1.4 | -1.33 |
Carcinoma | 3.3 | 1.7 | 0.94 |
Celiac Disease | 2.2 | 2.1 | 0.05 |
Cerebral Palsy | 0.8 | 0.6 | 0.33 |
Chronic Fatigue Syndrome | 4.3 | 4.7 | -0.09 |
Chronic Kidney Disease | 2.9 | 0.4 | 6.25 |
Chronic Lyme | 0.3 | -0.3 | |
Chronic Obstructive Pulmonary Disease (COPD) | 2.5 | 0.7 | 2.57 |
Chronic Urticaria (Hives) | 1.5 | 1 | 0.5 |
Coagulation / Micro clot triggering bacteria | 2 | 0.7 | 1.86 |
Cognitive Function | 1.7 | 0.9 | 0.89 |
Colorectal Cancer | 5.9 | 1.3 | 3.54 |
Constipation | 1.1 | 0.1 | 10 |
Coronary artery disease | 2.7 | 1.4 | 0.93 |
COVID-19 | 7 | 8.1 | -0.16 |
Crohn's Disease | 6.7 | 2.7 | 1.48 |
Cushing's Syndrome (hypercortisolism) | 0.1 | 0.3 | -2 |
cystic fibrosis | 1 | 0.5 | 1 |
d-lactic acidosis (one form of brain fog) | 0.7 | 0.7 | |
deep vein thrombosis | 2.3 | 1 | 1.3 |
Denture Wearers Oral Shifts | 1.7 | 1.7 | |
Depression | 6.7 | 4.2 | 0.6 |
Dermatomyositis | 0.4 | 0.1 | 3 |
Eczema | 1.9 | 1.7 | 0.12 |
Endometriosis | 2.9 | 1.5 | 0.93 |
Eosinophilic Esophagitis | 0.2 | 0.4 | -1 |
Epilepsy | 2.7 | 1.3 | 1.08 |
erectile dysfunction | 1.1 | 0.1 | 10 |
Fibromyalgia | 1.5 | 1.8 | -0.2 |
Functional constipation / chronic idiopathic constipation | 3.8 | 2.9 | 0.31 |
gallstone disease (gsd) | 3.1 | 0.3 | 9.33 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.2 | 0.8 | 0.5 |
Generalized anxiety disorder | 2.9 | 1.1 | 1.64 |
giant cell arteritis | 0 | 0 | |
Glioblastoma | 0.4 | -0.4 | |
Gout | 1.6 | 0.3 | 4.33 |
Graves' disease | 0.9 | 1.4 | -0.56 |
Gulf War Syndrome | 0.5 | 1.1 | -1.2 |
Halitosis | 1.4 | 0.4 | 2.5 |
Hashimoto's thyroiditis | 2 | 0.6 | 2.33 |
Heart Failure | 3.7 | 0.5 | 6.4 |
hemorrhagic stroke | 0.9 | 0.9 | |
Hidradenitis Suppurativa | 1 | 1 | |
High Histamine/low DAO | 0.8 | 0.4 | 1 |
hypercholesterolemia (High Cholesterol) | 1.1 | 1.1 | |
hyperglycemia | 2 | 0.7 | 1.86 |
Hyperlipidemia (High Blood Fats) | 0.2 | 0.2 | |
hypersomnia | 0.1 | -0.1 | |
hypertension (High Blood Pressure | 3 | 3.2 | -0.07 |
Hypothyroidism | 0.1 | 0.2 | -1 |
Hypoxia | 1.1 | 1.1 | |
IgA nephropathy (IgAN) | 1.6 | 2.8 | -0.75 |
Inflammatory Bowel Disease | 5.4 | 5.6 | -0.04 |
Insomnia | 1.9 | 1.1 | 0.73 |
Intelligence | 1.8 | 0.6 | 2 |
Intracranial aneurysms | 1.2 | 0.1 | 11 |
Irritable Bowel Syndrome | 4.8 | 2.3 | 1.09 |
ischemic stroke | 2.3 | 0.9 | 1.56 |
Liver Cirrhosis | 4.7 | 2.7 | 0.74 |
Long COVID | 4.5 | 4.1 | 0.1 |
Low bone mineral density | 0.2 | -0.2 | |
Lung Cancer | 1.1 | 0.8 | 0.38 |
Lymphoma | 0.6 | 0.1 | 5 |
Mast Cell Issues / mastitis | 1.4 | 0.5 | 1.8 |
ME/CFS with IBS | 0.7 | 1.8 | -1.57 |
ME/CFS without IBS | 1.2 | 1.8 | -0.5 |
membranous nephropathy | 0.4 | 0.4 | |
Menopause | 0.9 | 0 | 0 |
Metabolic Syndrome | 5.7 | 4.2 | 0.36 |
Mood Disorders | 6 | 3.4 | 0.76 |
multiple chemical sensitivity [MCS] | 1.1 | 1.1 | |
Multiple Sclerosis | 3.6 | 3.6 | 0 |
Multiple system atrophy (MSA) | 0.2 | 0.4 | -1 |
myasthenia gravis | 1 | 0 | 0 |
neuropathic pain | 1.3 | -1.3 | |
Neuropathy (all types) | 0.4 | 1.3 | -2.25 |
neuropsychiatric disorders (PANDAS, PANS) | 1.5 | 1.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.1 | 1.7 | 1.41 |
NonCeliac Gluten Sensitivity | 0.4 | 0.4 | 0 |
Obesity | 7 | 5.6 | 0.25 |
obsessive-compulsive disorder | 4 | 3.1 | 0.29 |
Osteoarthritis | 2.6 | 1.2 | 1.17 |
Osteoporosis | 1.2 | 1.1 | 0.09 |
pancreatic cancer | 1.3 | 0.4 | 2.25 |
Parkinson's Disease | 5.5 | 3.5 | 0.57 |
Polycystic ovary syndrome | 5 | 2.2 | 1.27 |
Postural orthostatic tachycardia syndrome | 0 | 0.3 | 0 |
Premenstrual dysphoric disorder | 0.1 | 0.3 | -2 |
primary biliary cholangitis | 0.8 | 1.3 | -0.63 |
Primary sclerosing cholangitis | 1.5 | 1.9 | -0.27 |
Psoriasis | 2.5 | 1.6 | 0.56 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5.7 | 2 | 1.85 |
Rosacea | 0.5 | 0 | 0 |
Schizophrenia | 3.6 | 1.1 | 2.27 |
scoliosis | 0.9 | 0.4 | 1.25 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.3 | 1.8 | 0.28 |
Sleep Apnea | 1.4 | 0.4 | 2.5 |
Slow gastric motility / Gastroparesis | 1.2 | 0.1 | 11 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.7 | 0.2 | 7.5 |
Stress / posttraumatic stress disorder | 2.2 | 0.8 | 1.75 |
Systemic Lupus Erythematosus | 3.5 | 1 | 2.5 |
Tic Disorder | 1.1 | 1.4 | -0.27 |
Tourette syndrome | 0.8 | 0.3 | 1.67 |
Type 1 Diabetes | 2.3 | 1.7 | 0.35 |
Type 2 Diabetes | 5.6 | 4.9 | 0.14 |
Ulcerative colitis | 4.2 | 4.3 | -0.02 |
Unhealthy Ageing | 3.3 | 1 | 2.3 |
Vitiligo | 1.8 | 0.7 | 1.57 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]